Evidence map›Paper›PMID 29282011›Full record

ArticleBMC cancer2017

Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.

Sabrina Falkowski, Jean-Baptiste Woillard, Deborah Postil, Nicole Tubiana-Mathieu, Eric Terrebonne, Antoine Pariente, Denis Smith, Rosine Guimbaud, Claire Thalamas, Koukeb Rouguieg-Malki and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. UGT1A6 in pancreatic cancer: a promising prognostic biomarker and therapeutic target.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Sabrina FalkowskiOncology Department, CHU Limoges, Limoges, France.
Jean-Baptiste WoillardUMR-1248, Inserm, CHU Limoges, Univ. Limoges, Limoges, France.ORCID 0000-0003-1695-0695
Deborah PostilClinical Investigation Centre, CHU Limoges, Limoges, France.
Nicole Tubiana-MathieuOncology Department, CHU Limoges, Limoges, France.
Eric TerrebonneHepato-gastro-enterology Department, University Hospital Bordeaux, Bordeaux, France.
Antoine ParientePharmaco-epidemiology unit, University Hospital Bordeaux, Bordeaux, France.
Denis SmithOncology Department, University Hospital Bordeaux, Bordeaux, France.
Rosine GuimbaudDigestive Oncology Department, University Hospital Toulouse, Toulouse, France.
Claire ThalamasClinical Investigation Centre, University Hospital Toulouse, Toulouse, France.
Koukeb Rouguieg-MalkiUMR-1248, Inserm, CHU Limoges, Univ. Limoges, Limoges, France.
Pierre MarquetUMR-1248, Inserm, CHU Limoges, Univ. Limoges, Limoges, France.
Nicolas PicardUMR-1248, Inserm, CHU Limoges, Univ. Limoges, Limoges, France. nicolas.picard@unilim.fr.
Inserm · FRCentre Hospitalier Universitaire de Limoges · FRBordeaux Population Health · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAssociations between polymorphisms of UDP-glucuronosyltransferases (UGTs) or efflux transporters (e.g., P-glycoprotein and MRP2) and different types of cancer have been described, whereas the role of influx transporters (e.g. OATP1B1 and OATP2B1) has been seldom explored. The GenColon study investigated potential associations between variant alleles of UGTs, efflux and influx transporters and CRC.

methodsThree hundred CRC cases were matched with 300 controls for age, sex and enrolment site. Fifteen SNPs in UGT1A6-9, UGT2B7, ABCB1, ABCC2, SLCO1B1 and SLCO2B1 genes were characterized using Taqman® PCR. Using multivariate conditional logistic regression, we investigated the relationships between CRC and "environmental" risk factors (physical activity, housing and working areas, consumption of red meat, tobacco, alcohol); genetic polymorphisms, in the study population and in the subgroups with "environmental" risk factors.

resultsNo significant association was observed for the analyzed SNPs (or haplotypes). However, an increased CRC risk was found in carriers of the UGT1A8 rs1042597-G variant allele (additive risk OR = 3.39[1.29-8.89], p = 0.02951) in the subgroup of meat-consumers (n = 84), and in carriers of the ABCB1 rs1045642-T (exon26) variant allele (additive risk; OR = 1.89[1.10-3.39], p = 0.0257) in the "never alcohol consumption subgroup" (n = 125). In addition, as previously reported, the following CRC risk factors were identified: absence of physical activity (OR = 6.35[3.70-10.9], p < 0.0001), living or working in rural or mix area (OR = 2.50[1.48-4.23], p = 0.0006 and OR = 2.99[1.63-5.48], p = 0.004, respectively) and tobacco exposure >30 years (3.37[1.63-6.96], p = 0.0010).

conclusionsVariant genotypes of influx transporters (OATP1B1 and 2B1) were not associated with CRC. This study confirmed the influence of lifestyle factors, but not the previously reported detrimental effect of SNPs in intestinal UGTs or efflux transporters, except for a UGT1A8 variant in subjects consuming meat and the exon 26 SNP of ABCB1 in the never alcohol consumption subgroup.

trial registrationRegistered in Direction Générale de la Santé the 1st July 2008 under the number DGS2008-0144.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAgedBiomarkers, TumorCase-Control StudiesColorectal NeoplasmsFemaleFollow-Up StudiesGlucuronosyltransferaseHumansMaleMembrane Transport ProteinsMultidrug Resistance-Associated Protein 2PrognosisRisk FactorsABCC2 protein, humanBiomarkers, TumorGlucuronosyltransferaseMembrane Transport ProteinsMultidrug Resistance-Associated Protein 2Colorectal cancerEfflux transportersOATPPharmacogeneticsUGT

Identifiers

PMID29282011
PMCPMC5745594
OpenAlexW2778159818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.